Cartesian Therapeutics (RNAC) Stock Price & Financial Analysis
Cartesian Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Cartesian Therapeutics
What is the current stock price for RNAC?
As of the latest trading session, RNAC stock trades at $6.26. The 52-week range is $5.60–$15.57, with a day range of $6.16–$6.36.
What is the P/E ratio for RNAC?
The P/E ratio (Price-to-Earnings) for RNAC is shown in the Key Statistics section. This valuation metric helps compare Cartesian Therapeutics, Inc. to industry peers.
Does RNAC pay dividends?
Cartesian Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RNAC?
Based on 3 analysts, the consensus for RNAC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of RNAC?
Cartesian Therapeutics's market capitalization is $162.6M, classifying it as a micro-cap company. Cartesian Therapeutics operates in the Healthcare sector within the Biotechnology industry.